Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "drugmaker Johnson"


4 mentions found


OLYMPIA, Wash. (AP) — The Washington state attorney general announced a $149.5 million settlement Wednesday with drugmaker Johnson & Johnson, more than four years after the state sued the company over its role fueling the opioid addiction crisis. If approved, the deal would send over $20 million more to respond to the opioid crisis than if the state had signed onto a national settlement in 2021 involving Johnson & Johnson, the attorney general’s office said. Washington state’s Democratic attorney general sued Johnson & Johnson in 2020, alleging that it helped drive the pharmaceutical industry’s expansion of prescription opioids. “The Company’s actions relating to the marketing and promotion of important prescription opioid medications were appropriate and responsible,” according to the statement. The attorney general’s office noted that the company was one of the largest suppliers of the raw narcotic materials needed to produce opioid drugs.
Persons: drugmaker Johnson, Johnson, Bob Ferguson, Democratic Sen, June Robinson, Geoff Mulvihill Organizations: Washington State Department of Health, Johnson, Democratic Locations: The Washington, U.S, Washington, Cherry Hill , New Jersey
WASHINGTON, Dec 29 (Reuters) - The U.S. government on Thursday filed a lawsuit accusing AmerisourceBergen Corp (ABC.N), one of the nation's largest drug distributors, of helping ignite the nation's deadly opioid epidemic by failing to report hundreds of thousands of suspicious orders of prescription painkillers. The government said AmerisourceBergen had since 2014 systematically refused or negligently failed to flag suspicious orders by pharmacy customers when it had reason to know that opioids were being diverted to illegal channels. "For years, AmerisourceBergen prioritized profits over its legal obligations and over Americans' well-being," Associate Attorney General Vanita Gupta told reporters. In a statement, AmerisourceBergen called the lawsuit an improper attempt to "shift blame" and the burdens of law enforcement from the Justice Department and DEA to the companies they regulate. The Justice Department said AmerisourceBergen for years understaffed and unfunded programs designed to ensure compliance with the Controlled Substances Act.
Dec 29 (Reuters) - The U.S. government on Thursday filed a civil lawsuit accusing the drug distributor AmerisourceBergen Corp (ABC.N) of contributing to the deadly U.S. opioid epidemic by repeatedly failing to report suspicious orders of prescription painkillers. "The United States brings this suit to hold defendants accountable for their egregious failure to report suspicious orders and their role in contributing to the opioid epidemic," the Justice Department said in its complaint. The company has long denied contributing to the opioid epidemic. Thursday's lawsuit is latest in a series of criminal and civil actions the Justice Department has pursued against companies accused of fueling the opioid epidemic. Reporting by Jonathan Stempel in New York; Editing by Chizu Nomiyama and David GregorioOur Standards: The Thomson Reuters Trust Principles.
The proposed settlement brings a nationwide tally of finalized and completed settlements between companies and governments to more than $45 billion. In recent years, opioid deaths have soared to record levels around 80,000 a year. The settlement was announced as litigation over the role of pharmacies in the opioid crisis has ramped up. Only a handful of opioid settlements have had bigger dollar figures attached than the CVS plan. Distributors AmerisourceBergen, Cardinal Health and McKesson this year finalized a combined settlement worth $21 billion and drugmaker Johnson & Johnson finalized a $5 billion deal.
Total: 4